Ticker
SNDXCompany Name
SYNDAX PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Net Cash Flow - Operations | Operating Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -302.67M | -387.14% | $ 78.18M |
3/31/2025 | $ -286.52M | -655.32% | $ 43.72M |
12/31/2024 | $ -274.9M | -1160.91% | $ 23.68M |
9/30/2024 | $ -258.86M | -1617.9% | $ 16M |
6/30/2024 | $ -241.19M | -6891.29% | $ 3.5M |
3/31/2024 | $ -204.92M | 0% | $ 0 |
12/31/2023 | $ -160.6M | 0% | $ 0 |
9/30/2023 | $ -142.15M | 0% | $ 0 |
6/30/2023 | $ -126.04M | 0% | $ 0 |
3/31/2023 | $ -130.97M | 0% | $ 0 |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations / Revenues
(=) OCF %
OCF % for SYNDAX PHARMACEUTICALS INC is calculated as follows: CF - Operations [ $ -68.36M ] / Revenues [ $ 1.52M ]
(=) OCF % [ -4508.97% ]
Minimum
Jun 30, 2024
Maximum
Dec 31, 2021
Average
Median
filtered constituents | 3.25K |
---|---|
min | -57.27% |
max | 77.08% |
average | 14.31% |
median | 12.65% |
std | 21.13% |